1. EP-2066: Phospholipase Cε as a biomarker of prostate cancer radioresistance. (April 2016) Authors: Tyutyunnykova, A.; Telegeev, G.; Dubrovska, A. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S975 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0152: Glutamine metabolism as potential biomarker and target for prostate cancer radiosensitization. (April 2018) Authors: Dubrovska, A.; Tyutyunnykova, A.; Chen, O.; Linge, A.; Löck, S.; Telychko, V.; Richter, S.; Hein, L.; Toma, M.; Zschaeck, S.; Eisenhofer, G.; Wirth, M.; Kunz-Schughart, L.; Tawk, B.; Schwager, C.; Abdollahi, A.; Baretton, G.; Krause, M.; Baumann, M. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PV-0373: Epigenetic and metabolic reprogramming as a target for prostate tumor radiosensitization. (May 2017) Authors: Dubrovska, A.; Peitzsch, C.; Tyutyunnykova, A.; Cojoc, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗